CNV mapping onto the entire genome revealed that the TPX2 segment was considerably amplified in the endometrial tumor group when compared with that in the normal endometrial group; these findings were consistent with the TPX2 mRNA expression data (Figures 4(a) and 4(b)). The gene discussed is TPX2; the disease is endometrium neoplasm.